Form 4: Encompass Health Director Boosts Stake Through Equity Awards and Deferred Plan

Sentiment:

Insider Transaction Report 16 July 2025 2:08 PM

Encompass Health Corp. Director Edward M Christie III increased his beneficial ownership of company stock through a restricted stock unit award and purchases via a deferred compensation plan.

Better than expectedA director increased their beneficial ownership of company stock, which typically signals confidence in the company's future performance.The acquisitions were made through a deferred compensation plan and dividend reinvestment, indicating a long-term investment strategy by the insider.

Summary

Director Edward M Christie III acquired 8 Restricted Stock Units (RSUs) on July 15, 2025, as part of a dividend reinvestment program.
The RSUs were credited based on a $0.17 per share dividend and a closing stock price of $107.28 on the dividend payment date.
On July 16, 2025, Mr. Christie acquired an additional 260 shares of Encompass Health Common Stock at a weighted average price of $106.48 per share, with purchases ranging from $106.48 to $106.68.
These 260 shares were purchased through the Company's Directors Deferred Stock Investment Plan, funded by deferred director fees and reinvested cash dividends.
Following these transactions, Mr. Christie's direct beneficial ownership of Encompass Health Common Stock increased to 6,674 shares.

Sentiment

Score: 8

Explanation: The filing indicates increased insider ownership by a director through both RSU awards and direct stock purchases via a deferred compensation plan, which is generally viewed as a strong positive signal of confidence in the company's future prospects and aligns insider interests with shareholders.

Positives

Increased insider ownership by a director, signaling confidence in the company's future.
Participation in a deferred stock investment plan demonstrates long-term commitment.
Dividend reinvestment indicates a strategy to compound returns.

Industry Context

This transaction reflects a standard practice of insider stock acquisition and deferred compensation within the healthcare services industry, where director compensation often includes equity components to align interests with shareholders.

Comparison to Industry Standards

The acquisition of shares by a director through a deferred compensation plan and dividend reinvestment is a common practice across various industries, including healthcare, to align management and director interests with shareholders.
While specific comparable companies or projects are not detailed in this filing, such plans are widely adopted by companies like HCA Healthcare, Universal Health Services, or Tenet Healthcare, which also utilize equity-based compensation for their non-employee directors to foster long-term commitment and incentivize performance.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Compensation Policy Implementation	The Directors Deferred Stock Investment Plan, effective November 1, 2007, allows non-employee directors to defer fees for stock purchases, aligning director interests with shareholders through equity ownership and dividend reinvestment.	2007-11-01	Enhances alignment between director incentives and shareholder value by increasing director equity ownership.

Related Party Transactions

Director Edward M Christie III acquired 260 shares of common stock through the Company's Directors Deferred Stock Investment Plan, funded by deferred director fees and reinvested dividends.
Director Edward M Christie III was awarded 8 Restricted Stock Units (RSUs) as part of a dividend payment on common stock, a standard component of non-employee director compensation.

Stakeholder Impact

Shareholders: Increased confidence due to a director's increased stake, signaling belief in the company's future.
Directors: Participation in deferred compensation plans provides a mechanism for long-term wealth accumulation tied to company performance.

Key Dates

Date	Description
2007-11-01	Effective date of the Directors Deferred Stock Investment Plan of the Company.
2024	Year non-employee directors made elections to defer fixed percentages of their director fees for 2025 under the Deferred Stock Investment Plan.
2025-07-15	Date Encompass Health paid a dividend of $0.17 per share on its common stock and the closing price was $107.28. Also, the date 8 Restricted Stock Units (RSUs) were awarded to Director Edward M Christie III.
2025-07-16	Date Director Edward M Christie III acquired 260 shares of common stock through the Directors Deferred Stock Investment Plan.

Recommendation

hold

Keywords

Encompass Health Corp, EHC, SEC Form 4, Insider Trading, Director Stock Purchase, Restricted Stock Units, Dividend Reinvestment, Deferred Compensation Plan, Corporate Governance, Stock Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.